WallStreetZenWallStreetZen

NYSEMKT: OSTX
Os Therapies Inc Earnings Dates, Reports, Calls

Os Therapies earnings were N/A for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest OSTX earnings report on Jun 30, 2024 announced Q2 2024 earnings of -$1.6M, up 4.5% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, OSTX reported annual earnings of -$7.9M, with 24.1% growth.

OSTX earnings history

Current Revenue
$0.0
Current Earnings
$0.0
Current Profit Margin
0%

OSTX Return on Equity

Insufficient data to display

OSTX Return on Assets

Insufficient data to display

Be the first to know when OSTX announces earnings.

OSTX Return on Capital Employed

Current Company
0%
Current Industry
21.3%

OSTX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
OSTXN/AN/AN/AN/A
VOR-$109.60M-$118.09MN/A-$1.73
IMRX-$55.32M-$56.07MN/A-$1.91
CSBR-$1.56M-$3.40MN/A-$0.25
THTX$10.14M-$2.34MN/A-$0.04

Os Therapies Earnings Reports & History FAQ

What were Os Therapies's earnings last quarter?

Os Therapies (NYSEMKT: OSTX) reported Q2 2024 earnings per share (EPS) of -$0.26, up 44.68% year over year. Total OSTX earnings for the quarter were -$1.56 million. In the same quarter last year, Os Therapies's earnings per share (EPS) was -$0.47.

If you're new to stock investing, here's how to buy Os Therapies stock.

Is Os Therapies profitable or losing money?

As of the last Os Therapies earnings report, Os Therapies is currently losing money. Os Therapies's net profit (also called net income) for the twelve months ending Jun 30, 2024 was N/A, a N/A decrease year over year.

What was OSTX's earnings growth in the past year?

As of Os Therapies's earnings date in Q4 2024, Os Therapies's earnings has grown year over year. OSTX earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.